Onct insider trading
WebInsider Purchases - Short Term Profit Analysis. In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Marc Steven Hanover in ONCT / Oncternal Therapeutics Inc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. WebONCT insider trading, corporate lobbying, Congressional trading, social media sentiment, stock price movement, and more ONCT - Oncternal Therapeutics, Inc. Common Stock Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need.
Onct insider trading
Did you know?
WebUncover the latest insider trading activity for Oncternal Therapeutics, Inc. (ONCT). Know which insiders are buying and selling along with top shareholders and ownership … Web24. feb 2024. · Oncternal Therapeutics Inc. (ONCT) latest news, insider trading and hedge fund ownership data provided by Insider Monkey.
WebOncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include … WebFiling Date T Date Ticker Sector Ind Industry Owner oSt Rel Title T TVal Price L Qty oc Own H r2y r1y r6m r3m r6w r3w r7d r3d f1d f1w f1m f3m f6m f1y
Web1 day ago · SAN DIEGO, April 13, 2024 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that two key industry opinion leaders and management will participate in Oppenheimer & Co.’s Virtual Fireside Chat: … Web12. apr 2024. · Their ONCT share price forecasts range from $4.00 to $9.00. On average, they anticipate the company's share price to reach $6.67 in the next twelve months. This …
WebInsider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oncternal Therapeutics, Inc. (ONCT) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oncternal Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1260990.
WebShares of the clinical-stage biopharmaceutical company, Oncternal Therapeutics, ( NASDAQ: ONCT) cratered in morning trading on Tuesday after the company announced a “strategic reprioritization” and halted two cancer studies. This included the Phase 3 study and the Phase 1 study of zilovertamab in combination with ibrutinib. The company also ... brew n bake jackson texasbrew nation llcWeb10. apr 2024. · A high-level overview of Oncternal Therapeutics, Inc. (ONCT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … brew n bites cafeWebONCT / Oncternal Therapeutics Inc off-exchange short sale volume is shown in the following chart. Short Sale volume shows the number of trades marked as short sales in various trading venues. For more information on how to interpret this data, read this information notice provided by FINRA. Update Frequency: Daily at Close of Day brew nation celina ohio menuWeb23. feb 2024. · In the last 2 years, insiders at Oncternal Therapeutics, Inc have sold an estimated value of $80.77K and bought an estimated value of $2.89M worth of shares. Insider trading is most common in June ... brew n bottle busseltonWebThe latest insider trading activity on ONCT stock, showing all insider transactions on Oncternal Therapeutics Inc over the past 6 quarters. county abbreviation kansasWebFind out the latest and most up-to-date insider trades for Oncternal Therapeutics Inc (ONCT) at GuruFocus.com. 🚀 Enjoy a 7-Day Free Trial Thru Apr 02, 2024! Sign Up county access line san diego